Proteome Sciences (LON:PRM) Shares Down 13.8% – Here’s Why

Proteome Sciences plc (LON:PRM)’s stock price was down 13.8% during mid-day trading on Thursday . The stock traded as low as GBX 2.89 ($0.04) and last traded at GBX 3.06 ($0.04). Approximately 1,115,348 shares traded hands during mid-day trading, an increase of 410% from the average daily volume of 218,703 shares. The stock had previously closed at GBX 3.55 ($0.05).

Proteome Sciences Price Performance

The business’s 50 day moving average price is GBX 4.05 and its 200-day moving average price is GBX 3.46. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The company has a market cap of £9.98 million, a PE ratio of -2.45 and a beta of 0.07.

Proteome Sciences (LON:PRM) last issued its quarterly earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) EPS for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.